These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37846319)

  • 21. Visual function in recovered ethambutol optic neuropathy.
    Woung LC; Jou JR; Liaw SL
    J Ocul Pharmacol Ther; 1995; 11(3):411-9. PubMed ID: 8590273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is critical flicker-fusion frequency a valid measure of visual fatigue? A post-hoc analysis of a double-masked randomised controlled trial.
    Singh S; Downie LE; Anderson AJ
    Ophthalmic Physiol Opt; 2023 Mar; 43(2):176-182. PubMed ID: 36416367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
    Narayan RN; McCreary M; Conger D; Wang C; Greenberg BM
    Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
    Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
    Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of critical flicker fusion frequency measurement and its laterality for evaluating compressive optic neuropathy due to pituitary neuroendocrine tumors.
    Taguchi A; Kinoshita Y; Tokumo K; Tominaga A; Kiuchi Y; Yamasaki F; Horie N
    Neurosurg Rev; 2022 Dec; 46(1):4. PubMed ID: 36471083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography in central nervous system demyelinating diseases related optic neuritis.
    Mekhasingharak N; Laowanapiban P; Siritho S; Satukijchai C; Prayoonwiwat N; Jitprapaikulsan J; Chirapapaisan N;
    Int J Ophthalmol; 2018; 11(10):1649-1656. PubMed ID: 30364209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.
    Stiebel-Kalish H; Lotan I; Brody J; Chodick G; Bialer O; Marignier R; Bach M; Hellmann MA
    PLoS One; 2017; 12(1):e0170847. PubMed ID: 28125740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.
    Asseyer S; Asgari N; Bennett J; Bialer O; Blanco Y; Bosello F; Camos-Carreras A; Carnero Contentti E; Carta S; Chen J; Chien C; Chomba M; Dale RC; Dalmau J; Feldmann K; Flanagan EP; Froment Tilikete C; Garcia-Alfonso C; Havla J; Hellmann M; Kim HJ; Klyscz P; Konietschke F; La Morgia C; Lana-Peixoto M; Leite MI; Levin N; Levy M; Llufriu S; Lopez P; Lotan I; Lugaresi A; Marignier R; Mariotto S; Mollan SP; Ocampo C; Cosima Oertel F; Olszewska M; Palace J; Pandit L; Peralta Uribe JL; Pittock S; Ramanathan S; Rattanathamsakul N; Saiz A; Samadzadeh S; Sanchez-Dalmau B; Saylor D; Scheel M; Schmitz-Hübsch T; Shifa J; Siritho S; Sperber PS; Subramanian PS; Tiosano A; Vaknin-Dembinsky A; Mejia Vergara AJ; Wilf-Yarkoni A; Zarco LA; Zimmermann HG; Paul F; Stiebel-Kalish H
    Front Neurol; 2023; 14():1102353. PubMed ID: 36908609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody.
    Deschamps R; Philibert M; Lamirel C; Lambert J; Vasseur V; Gueguen A; Bensa C; Lecler A; Marignier R; Vignal C; Gout O
    Mult Scler; 2021 May; 27(6):855-863. PubMed ID: 32633601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different visual evoked potentials in neuromyelitis optica spectrum disorder-related optic neuritis and idiopathic demyelinating optic neuritis: a prospective longitudinal analysis.
    Zheng C; Wang L; Xu X; Zhou M; Liu K; Zhang Y; Zhao X; Lu L; Qiu W; Zhang X; Yang H
    BMC Ophthalmol; 2022 Sep; 22(1):376. PubMed ID: 36131262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of different treatment and prevention regimens on myelin oligodendrocyte glycoprotein antibody-related optic neuritis].
    Tan X; Wang L; Zhang YX; Liu KQ; Zhou L; Chen D; Zhou ML; Qiu W; Yang H
    Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(7):498-503. PubMed ID: 32164099
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of Steroid Pulse Therapy Responsiveness in Myelin-Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis.
    Takai Y; Yamagami A; Iwasa M; Inoue K; Wakakura M; Takahashi T; Tanaka K
    Cureus; 2024 Mar; 16(3):e56673. PubMed ID: 38646337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MOG-IgG- versus AQP4-IgG-Positive Optic Neuritis in Thailand: Clinical Characteristics and Long-Term Visual Outcomes Comparison.
    Narongkhananukul C; Padungkiatsagul T; Jindahra P; Khongkhatithum C; Thampratankul L; Vanikieti K
    Clin Ophthalmol; 2020; 14():4079-4088. PubMed ID: 33273804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning.
    Sotirchos ES; Filippatou A; Fitzgerald KC; Salama S; Pardo S; Wang J; Ogbuokiri E; Cowley NJ; Pellegrini N; Murphy OC; Mealy MA; Prince JL; Levy M; Calabresi PA; Saidha S
    Mult Scler; 2020 Oct; 26(11):1360-1371. PubMed ID: 31364464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising recovery biomarkers after first event acute demyelinating optic neuritis.
    Klineova S; Kupersmith M
    Mult Scler Relat Disord; 2020 Oct; 45():102400. PubMed ID: 32702643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
    Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
    JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.
    Naismith RT; Tutlam NT; Xu J; Shepherd JB; Klawiter EC; Song SK; Cross AH
    Neurology; 2009 Jul; 73(1):46-52. PubMed ID: 19564583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Pattern Reversal and Flash Visual Evoked Potential Latencies With Optical Coherence Tomography Measures in Patients With Optic Neuropathy and Patients With Multiple Sclerosis Without Optic Neuropathy.
    Moussa H; Sawaya RA; Deeb R; El Ayoubi N
    J Clin Neurophysiol; 2022 Nov; 39(7):637-642. PubMed ID: 33555731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromatic visual evoked potentials indicate early dysfunction of color processing in young patients with demyelinating disease.
    Tekavčič Pompe M; Perovšek D; Šuštar M
    Doc Ophthalmol; 2020 Oct; 141(2):157-168. PubMed ID: 32157494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after orbital decompression for dysthyroid optic neuropathy.
    Cheng S; Yu Y; You Y; Chen J; Pi X; Wang X; Jiang F
    Int Ophthalmol; 2021 Sep; 41(9):3121-3133. PubMed ID: 33945060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.